Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home
Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home
Enrolling by invitation · NCT06488846 · Registry updated 2026-05-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Enrolling by invitation | Not stated | 2026-05-01 | NCT06488846 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centers for Disease Control and Prevention | 84 |
| University of California, San Francisco | 637 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Division of Prevention Science, Center for AIDS Prevention Studies (CAPS) | San Francisco | United States | 2 |